Cargando…

Genetically modified large animal models for investigating neurodegenerative diseases

Neurodegenerative diseases represent a large group of neurological disorders including Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease, and Huntington’s disease. Although this group of diseases show heterogeneous clinical and pathological phenotypes, they share important path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Weili, Chen, Xiusheng, Li, Shihua, Li, Xiao-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690884/ https://www.ncbi.nlm.nih.gov/pubmed/34933675 http://dx.doi.org/10.1186/s13578-021-00729-8

Ejemplares similares

New pathogenic insights from large animal models of neurodegenerative diseases
por: Yin, Peng, et al.
Publicado: (2022)

CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
por: Tu, Zhuchi, et al.
Publicado: (2015)

Use of large animal models to investigate Huntington's diseases
por: Yan, Sen, et al.
Publicado: (2019)

Mitochondrial-Dependent and Independent Functions of PINK1
por: Chen, Xiusheng, et al.
Publicado: (2022)

Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
por: Long, Houfang, et al.
Publicado: (2022)

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
por: Yang, Weili, et al.
Publicado: (2016)

Therapeutic potential of berberine against neurodegenerative diseases
por: JIANG, WenXiao, et al.
Publicado: (2015)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Bridging the gap: large animal models in neurodegenerative research
por: Eaton, S. L., et al.
Publicado: (2017)

Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
por: Wyse, Robert D., et al.
Publicado: (2014)

Zebrafish and Medaka: Important Animal Models for Human Neurodegenerative Diseases
por: Wang, Jing, et al.
Publicado: (2021)

Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022)

Investigating Causality and Shared Genetic Architecture between Neurodegenerative Disorders and Inflammatory Bowel Disease
por: Zeng, Ruijie, et al.
Publicado: (2023)

Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models
por: Tomioka, Ikuo, et al.
Publicado: (2018)

Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
por: Zhu, Longhong, et al.
Publicado: (2023)

Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
por: Jia, Qingqing, et al.
Publicado: (2022)

Genetic modifiers of rodent animal models: the role in cataractogenesis
por: Wada, Kenta, et al.
Publicado: (2019)

Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms
por: Chen, Xi, et al.
Publicado: (2012)

Genetic variants associated with neurodegenerative Alzheimer disease in natural models
por: Salazar, Claudia, et al.
Publicado: (2016)

A CRISPR monkey model unravels a unique function of PINK1 in primate brains
por: Yang, Weili, et al.
Publicado: (2019)

Genetic targeting of astrocytes to combat neurodegenerative disease
por: Kéry, Rachel, et al.
Publicado: (2019)

Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease
por: Pinnapureddy, Ashish R., et al.
Publicado: (2015)

Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: a systematic review
por: Yap, Kah Hui, et al.
Publicado: (2022)

Calabria as a Genetic Isolate: A Model for the Study of Neurodegenerative Diseases
por: Bruno, Francesco, et al.
Publicado: (2022)

NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases
por: Na, Dokyun, et al.
Publicado: (2013)

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
por: García, Julio-César, et al.
Publicado: (2018)

Large Animal Models for Investigating Cell Therapies of Stress Urinary Incontinence
por: Amend, Bastian, et al.
Publicado: (2021)

The Sheep as a Large Animal Model for the Investigation and Treatment of Human Disorders
por: Banstola, Ashik, et al.
Publicado: (2022)

Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
por: de Bem, Andreza Fabro, et al.
Publicado: (2021)

The role of genetics in neurodegenerative dementia: a large cohort study in South China
por: Jiao, Bin, et al.
Publicado: (2021)

Genetics of neurodegenerative diseases
por: Pulst, Stefan M.
Publicado: (2016)

Dictyostelium discoideum as a Model for Investigating Neurodegenerative Diseases
por: Haver, Holly N., et al.
Publicado: (2021)

Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans
por: Wang, Yiru Anning, et al.
Publicado: (2017)

Large animal models of cardiovascular disease
por: Tsang, H. G., et al.
Publicado: (2016)

CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys
por: Yang, Weili, et al.
Publicado: (2019)

Large Mammalian Animal Models of Heart Disease
por: Camacho, Paula, et al.
Publicado: (2016)

Large animal models for chronic wasting disease
por: Mathiason, C. K.
Publicado: (2022)

Genetic manipulation for inherited neurodegenerative diseases: myth or reality?
por: Yu-Wai-Man, Patrick
Publicado: (2016)

Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
por: Perrone, Federica, et al.
Publicado: (2021)

Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning
por: Harada, Chikako, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t2p5maijfrmuirbd42g9de3g3e